Case 18-2018: A 45-Year-Old Woman with Hypertension, Fatigue, and Altered Mental Status

    June 2018 in “ The New England Journal of Medicine ”
    J. Carl Pallais, Andrew Z. Fenves, Michael T. Lu, Krzysztof Glomski
    Image of study
    TLDR A woman with Cushing's syndrome improved after surgery to remove a tumor causing the condition.
    In a case study from 2018, a 45-year-old woman with symptoms of Cushing's syndrome was diagnosed with the condition due to ectopic corticotropin secretion from a thymic neuroendocrine tumor. Her symptoms included hypertension, fatigue, altered mental status, hyperglycemia, hypokalemia, and metabolic alkalosis. Diagnostic tests revealed high urinary cortisol and corticotropin levels, and imaging located the ectopic source. The tumor was surgically removed, leading to significant postoperative improvement in her symptoms and allowing her to return to work. The patient's condition was monitored post-surgery without the need for ongoing glucocorticoid replacement, and chemotherapy was considered as a future treatment option if necessary.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 131 results

      community 1.5 years on fin/min progress pics, thoughts would be great!

      in Progress Pictures  69 upvotes 3 years ago
      A 42-year-old male shared his 1.5-year hair regrowth progress using 1.25mg finasteride daily and regular doses of minoxidil twice a day, and recently started using the Derminator 2. He also mentioned his battle with cancer and Cushing's syndrome, which affected his weight and hair.

      community [25, F] [RANT] Shedding since March 2020. This just isn’t fair.

      in Female  42 upvotes 3 years ago
      User "missbloombastic" has been experiencing hair loss since 2016 and tried min, fin, multivitamins, and spiro with mixed results. Another user shares their struggle with hair loss and its impact on self-esteem, while a third user suggests checking blood tests and confirming the cause of hair loss.

      community Breezula will hit the market in 2026, Cosmo Pharmaceuticals statement!

      in Product  52 upvotes 8 months ago
      Breezula, a hair loss treatment, is expected to cost around $100 a month and is anticipated to be released in 2026. The effectiveness of Breezula is debated, with some suggesting it loses effectiveness over time and others arguing it maintains hair compared to baseline.

      community Medications that cause extra hair growth

      in Research/Science  123 upvotes 1 year ago
      The post discusses the side effects of various drugs causing excess hair growth, questioning why only minoxidil is used in the hair loss industry. The conversation includes users sharing their experiences and concerns about potential side effects of these drugs, with some preferring baldness over potential health risks.

      community My Dad seems to get his hair back?

      in Question  15 upvotes 5 years ago
      A user's father, mostly bald for 20 years, is regrowing hair using a serum called "Skrzypovita Serum Pro" without minoxidil. The user is curious about which ingredients might be causing hair growth.

    Similar Research

    5 / 1000+ results